Genomic Screening for Malignant Hyperthermia Susceptibility.


Journal

Anesthesiology
ISSN: 1528-1175
Titre abrégé: Anesthesiology
Pays: United States
ID NLM: 1300217

Informations de publication

Date de publication:
01 12 2020
Historique:
pubmed: 9 9 2020
medline: 15 12 2020
entrez: 8 9 2020
Statut: ppublish

Résumé

It is timely to consider the utility and practicability of screening for malignant hyperthermia susceptibility using genomic testing. Here the authors pose a simple, but bold question: what would it take to end deaths from malignant hyperthermia? The authors review recent advances and propose a scientific and clinical pathway toward this audacious goal to provoke discussion in the field.

Identifiants

pubmed: 32898259
pii: 110480
doi: 10.1097/ALN.0000000000003547
pmc: PMC7658016
mid: NIHMS1619731
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1277-1282

Subventions

Organisme : NIAMS NIH HHS
ID : R01 AR053349
Pays : United States
Organisme : Intramural NIH HHS
ID : ZIA HG200387
Pays : United States

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2020, the American Society of Anesthesiologists, Inc. All Rights Reserved.

Références

Anesthesiology. 2002 Nov;97(5):1067-74
pubmed: 12411788
Anesth Analg. 1985 Jul;64(7):700-4
pubmed: 4014731
Anesth Analg. 2012 Jan;114(1):94-100
pubmed: 22052978
Genet Med. 2019 Feb;21(2):441-450
pubmed: 29930394
Anesthesiology. 2009 Jan;110(1):89-94
pubmed: 19104175
Anesthesiology. 2008 Apr;108(4):603-11
pubmed: 18362591
Anesthesiology. 2006 Jun;104(6):1146-54
pubmed: 16732084
Genet Med. 2015 May;17(5):405-24
pubmed: 25741868
Nature. 2019 Dec;576(7785):149-157
pubmed: 31634902
Br J Anaesth. 2019 Sep;123(3):e461-e463
pubmed: 31301762
Orphanet J Rare Dis. 2007 Apr 24;2:21
pubmed: 17456235
Nature. 2018 Oct;562(7726):217-222
pubmed: 30209399
Br J Anaesth. 2018 Oct;121(4):944-952
pubmed: 30236257
Nat Med. 2019 Jan;25(1):44-56
pubmed: 30617339
N Engl J Med. 2014 Jun 19;370(25):2418-25
pubmed: 24941179
Genet Med. 2013 Jul;15(7):565-74
pubmed: 23788249
Am J Health Syst Pharm. 2018 Feb 15;75(4):239-246
pubmed: 29436470
Br J Anaesth. 2010 Oct;105(4):417-20
pubmed: 20837722
Anesthesiology. 2019 Nov;131(5):957-959
pubmed: 31335544
Curr Protoc Hum Genet. 2019 Sep;103(1):e93
pubmed: 31479589
Genet Med. 2017 Feb;19(2):249-255
pubmed: 27854360

Auteurs

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH